BDBM50182093 1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)propyl)piperidin-4-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one::CHEMBL381369
SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1C(=O)OCc2ccccc12)-c1ccc(cc1)C(F)(F)F
InChI Key InChIKey=CPKFDNOZJRILFT-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 50182093
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 88nMAssay Description:Inhibition of cathepsin SMore data for this Ligand-Target Pair
TargetHLA class II histocompatibility antigen gamma chain(Human)
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair